Bone modifying agent: Clinical Trials

1 trial of Bone modifying agent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Active not recruiting 1

Follow Bone modifying agent: new trials by email Literature Review of Bone modifying agent trials Research Report on Bone modifying agent

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
Bone modifying agent - Breast Cancer, Castration-resistant Prostate Cancer
Phase 4Active not recruitingOttawa Hospital Research Institute2402020-10-092026-07-21

Conditions studied

Breast Neoplasms (1)

Sponsors

Ottawa Hospital Research Institute (1)

Countries

Canada (1)

Top investigators

Terry Ng, MD (1)